aplindore MR tablets or Placebo

DRUG2 trials

Sponsors

Neurogen Corporation

Conditions

Early Parkinson DiseaseRestless Legs Syndrome

Phase 2

Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease

TerminatedNCT00809302

Neurogen CorporationEarly Parkinson Disease

Start: 2008-12-31End: 2009-10-31Updated: 2009-08-28

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

TerminatedNCT00834327

Neurogen CorporationRestless Legs Syndrome

Start: 2009-02-28End: 2009-12-31Target: 230Updated: 2009-10-14